Associations Between Sex Hormones and SARS-CoV-2 Antibodies
2023
- 21Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage21
- Abstract Views20
- Downloads1
Artifact Description
The purpose of this study was to determine the association between sex hormone levels and the presence of SARS-CoV-2 antibodies. Using both salivary and blood samples, a predictive focused study was conducted to determine the odds of antibody presence at a particular time post infection in relation to estrogen and testosterone levels. The morbidity and mortality rates of COVID-19 has disproportionately impacted men greater than females. The structural and chemical differences between testosterone and estrogen may explain the disparities and indicate possible protective properties. We hypothesized that higher estradiol levels and lower testosterone levels will increase the odds of circulating SARS-CoV-2 antibodies. Collection of qualitative information and samples occurred on the Ursinus College campus. Participation was limited to Ursinus students, faculty, and staff. ELISA analysis revealed that 17ß-estradiol levels (R = 13.5%) impacted longevity of SARS-CoV-2 antibodies greater than testosterone (R = 3.3%). We concluded that the immunoenhancing effects of 17ß-estradiol have greater impacts on COVID-19 antibodies and may influence future COVID-19 protocols.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know